Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 50.92

-2.5%

3:27 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Doc Bones who wrote (7725)	1/15/2003 11:21:49 AM
From: A.J. Mullen	Read Replies (2) of 52153

I heard that report on the radio, but why should the "Naked DNA" approach be any safer? As I understand it, the current guess is that surplus genetic material stimulated another gene to overproduce a protein that led to leukemia. If anything, surely the Naked Dna approach is less controlled than insertion using a retrovirus? The FDA must have have some rationale for limiting the moratorium to viral treatments. Could anyone enlighten me? Is the ban on all viruses, or is it limited to retroviruses? Ashley Ps. This is a duplicate of a post on the Vical thread.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next